3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
2
Rhabdoid Tumor
1
Papillary renal cell carcinoma, sporadic
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Melanoma
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hereditary leiomyomatosis and renal cell cancer
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
11
fludarabine phosphate
8
Nivolumab
8
pembrolizumab
7
fludarabine
7
Mycophenolic Acid
6
Magnetic Resonance Spectroscopy
6
Filgrastim
6
Doxorubicin
6
Dacarbazine
6
Brentuximab Vedotin
6
Whole-Body Irradiation
5
Vinblastine
5
Granulocyte Colony-Stimulating Factor
5
Cyclosporine
5
Specimen Handling
4
Melphalan
4
Etoposide
4
Busulfan
4
pegfilgrastim
3
Tacrolimus
3
Radiotherapy
3
Thiotepa
2
Sirolimus
2
Radiation
2
Peripheral Blood Stem Cell Transplantation
2
Fluorodeoxyglucose F18
2
Cyclosporins
2
Clofarabine
2
Azacitidine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
Erlotinib Hydrochloride
×
30 days
×
Clear all
No trials found.